Protelight Pharmaceuticals

Jiangyin, China · Founded 2009 · In IPO Registration

Developer and manufacturer of novel antimicrobial peptide drugs and therapeutic candidates designed for drug-resistant infections, metabolic disorders, and autoimmune diseases. Protelight Pharmaceuticals is based in Jiangyin, China and was founded in 2009. Its last reported valuation was $352 million in Nov 2025. It has raised $115 million.

Last reported valuation

$351.9M

Oct 2026

Priced at

—

Total raised

$115.0M

Last round

—

How much has Protelight Pharmaceuticals raised?

$115.0Macross 0 recorded rounds

Free account

More of Protelight Pharmaceuticals with a free account

·The complete investor list: 12 names
·Watch Protelight Pharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Protelight Pharmaceuticals investors

12 investors are on record for Protelight Pharmaceuticals, including Shenzhen Yifeng Investment Management Enterprise, Infinity Group, Wuxi Guolian Development (Group) and Cherami Investment Group.

For fundraisers

Raising for a company like Protelight Pharmaceuticals?

12 investors have backed Protelight Pharmaceuticals.

See all 12 investors →

Frequently asked about Protelight Pharmaceuticals

How much has Protelight Pharmaceuticals raised?: Protelight Pharmaceuticals has raised $115.0M in total across 0 recorded funding rounds.